Biology Reference
In-Depth Information
levels in red blood cells.
Scand J Clin Lab Invest
61: 337-340
139 Westenfelder C, Baranowski RL (2000) Erythropoietin stimulates proliferation of human renal
carcinoma cells.
Kidney Int
58: 647-657
140 Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A (2001) Erythropoietin and
erythropoietin receptor expression in human cancer.
Cancer Res
61: 3561-3565
141 Stone P (2002) The measurement, causes and effective management of cancer-related fatigue.
Int
J Palliat Nurs
8: 120-128
142 Casadevall N (1995) Cellular mechanism of resistance to erythropoietin.
Nephrol Dial Transplant
10 Suppl 6: 27-30
143 Horl WH (1999) Is there a role for adjuvant therapy in patients being treated with epoetin?
Nephrol Dial Transplant
14 Suppl 2: 50-60
144 Besarab A, Frinak S, Yee J (1999) An indistinct balance: The safety and efficacy of parenteral iron
therapy.
J Am Soc Nephrol
10: 2029-2043
145 Allen DA, Breen C, Yaqoob MM, Macdougall IC (1999) Inhibition of CFU-E colony formation
in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.
J Investig Med
47: 204-211
146 Le Meur Y, Lorgeot V, Comte L, Szelag JC, Aldigier JC, Leroux-Robert C, Praloran V (2001)
Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship
with erythropoietin requirements.
Am J Kidney Dis
38: 510-517
147 Gallucci MT, Lubrano R, Meloni C, Morosetti M, Manca DV, Scoppi P, P a lombo G, Castello
MA, Casciani CU (1999) Red blood cell membrane lipid peroxidation and resistance to erythro-
poietin therapy in hemodialysis patients.
Clin Nephrol
52: 239-245
148 Rosenlof K, Fyhrquist F, Tenhunen R (1990) Erythropoietin, aluminium, and anaemia in patients
on haemodialysis.
Lancet
335: 247-249
149 Glaspy J, Cavill I (1999) Role of iron in optimizing responses of anemic cancer patients to ery-
thropoietin.
Oncology (Huntingt)
13: 461-473
150 Gadducci A, Cosio S, Fanucchi A, Genazzani AR (2001) Malnutrition and cachexia in ovarian
cancer patients: Pathophysiology and management.
Anticancer Res
21: 2941-2947
151 Del Mastro L, Gennari A, Donati S (1999) Chemotherapy of non-small-cell lung cancer: Role of
erythropoietin in the management of anemia.
Ann Oncol
10 Suppl 5: S91-S94
152 Tzioufas AG, Kokori SI, Petrovas CI, Moutsopoulos HM (1997) Autoantibodies to human recom-
binant erythropoietin in patients with systemic lupus erythematosus: Correlation with anemia.
Arthritis Rheum
40: 2212-2216
153 Vannucchi AM, Bosi A, Grossi A, Guidi S, Saccardi R, Bacci P, Lombardini L, Rossi-Ferrini P
(1993) The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.
Int J Artif Organs
16 Suppl 5: 8-12
154 Andriani A, Bibas M, Callea V, De Renzo A, Chiurazzi F, Marceno R, Musto P, Rotoli B (1996)
Autoimmune hemolytic anemia during alpha interferon treatment in nine patients with hemato-
logical diseases.
Haematologica
81: 258-260
155 Jose Gomez MI, Gonzalez DD, Mellado Pena MJ, Garcia Miguel MJ, Garcia Rodriguez MC,
Cilleruelo Ortega MJ, Martinez ZR, Fernandez CP, Martin FP (1992) Long-term follow-up study
of 35 children with AIDS treated with zidovudine (AZT). (Spanish).
An Esp Pediatr
36: 98-108
156 Bertero MT, Caligaris-Cappio F (1997) Anemia of chronic disorders in systemic autoimmune dis-
eases.
Haematologica
82: 375-381
157 Fisch P, Handgretinger R, Schaefer HE (2000) Pure red cell aplasia.
Br J Haematol
111:
1010-1022
